Trending Now
Ocugen Inc. (NASDAQ: OCGN) Submits IND to Commences OCU400 Clinical Study...
Ocugen Inc. (NASDAQ: OCGN) has submitted an Investigational New Drug application with the FDA to commence a Phase 1/2 clinical study of its modifier...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Outlook Therapeutics Inc. (NASDAQ: OTLK) Presents NORSE II ONS-5010 Study Data...
Outlook Therapeutics Inc. (NASDAQ: OTLK) has presented vital efficacy and safety data from the third phase NORSE Two ONS-5010 study. ONS-5010 is an experimental...
MAKE IT MODERN
LATEST REVIEWS
Investing in the Coming Oil Boom (MTDR, AGYP, FANG)
OPEC-plus, the extended version of OPEC that came together several years ago to drive more policy power back into the global cartel-based...
MAKE IT MODERN
PERFORMANCE TRAINING
Carvana (NYSE:CVNA) could move higher and here’s why
The QQQ’s gapped lower as a bit of panic sets into the overall market. Rate fears continue as the 10 year yield...
Should Wall Street be worried about Monkeypox
The World Health Organization reported 92 cases in 12 countries as of Saturday, with another 28 suspected cases under investigation. Cases have...
Stocks for the Bioelectronic Medicine Revolution (NVCR, EMED, ECOR)
Bioelectronic medicine is starting to gain widespread attention after years of skepticism. That skepticism is now being eroded by a growing wave of peer-reviewed...
Akebia Therapeutics Inc. (NASDAQ:AKBA) Announces Q3 Results And Updates About Pre-NDA Meeting For Vadadustat
Akebia Therapeutics Inc. (NASDAQ:AKBA) has announced its Q3 2020 results for the quarter ended September 30, 2020, and also offered a business update that...
Aimmune Therapeutics Inc (NASDAQ:AIMT) Announces the Findings from APPEAL-2 Evaluating Impact of Peanut Allergy...
We all know what it means to live with the threats of an allergy. There are hundreds of thousands of people living with life-threatening...
MAKE IT MODERN
